CESCA Therapeutics, Inc.


Total Votes: 1  
Interest: 463

(800) 783-8357
(916) 858-5100
2711 Citrus Road
Rancho Cordova, California 95742

Email Us
Home
View Mobile Site
Administrative Login

Display Number: 22366
CLIRST III Trial

The Critical Limb Ischemia Rapid Stemcell Treatment (CLIRST) III trial is a pivotal trial evaluating the safety and efficacy of Cesca’s SurgWerks-CLI platform, which utilizes a patient’s own adult stem cells  to stimulate the regeneration of blood vessels, promote wound healing and to save the limb from amputation . Previous clinical trials have demonstrated the regeneration of blood vessels and improved blood circulation in the limb by injection of a patient’s own bone marrow cells. 

The CLIRST III trial was approved by the US FDA and is expected to begin patient enrollment in late 2016.

Click Here to Learn More

Your browser must support cookies to use the shopping cart.
CESCA Therapeutics, Inc.
Robin Stracey
2711 Citrus Road
Rancho Cordova, CA 95742
(916) 858-5100

At Cesca Therapeutics, we develop and market integrated cellular therapies and delivery systems that advance the safe and effective practice of Regenerative Medicine.